COMMUNIQUÉS West-GlobeNewswire

Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach
18/02/2026
WALTHAM, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of [...]
MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
18/02/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient [...]
Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK’s Largest Retailer
18/02/2026
CHICAGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced a significant expansion of [...]
Design Therapeutics to Participate in Upcoming Investor Conferences
18/02/2026
CARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that [...]
As Worker Safety Scrutiny Intensifies, Mesa Labs Reinforces Why Primary Standard Calibration Is the Only Line of Defense
18/02/2026
OSHA standardizes on Mesa’s DryCal Defender technology for field enforcement as industry faces generational knowledge gap in flow calibration LAKEWOOD, Colo., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. ( [...]
Health Systems and Strategic Partners Unite to Address Widening Healthcare Gaps in Rural and Underserved Communities
18/02/2026
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The National Specialty Care Access Coalition (NSCAC), a collaboration of more than 20 major US health systems, today announced its launch to address the growing breakdown in [...]
LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary
18/02/2026
BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer [...]
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
18/02/2026
Conference Call Scheduled for Thursday, March 5, 2026 at 9:00 AM ET PORTLAND, Maine, Feb. 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that [...]
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
18/02/2026
Preliminary blinded CR rate showed 67% improvement over historical cytarabine response Roughly 35% of the subjects treated to date represent ventoclax regimen failures First 45 subjects treated on track for Q1 2026 [...]
Akari Therapeutics to Present at the 2026 Biocom Global Partnering & Investor Conference
18/02/2026
In-person presentation on Wednesday, February 25th at 11:00 AM PT TAMPA, Fla. and LONDON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody [...]
Theriva™ Biologics Licenses SYN-020 to Rasayana Therapeutics for Multiple Indications
18/02/2026
- Theriva received a $300,000 upfront payment at signing and is eligible for up to $38M in development, regulatory, and sales milestones along with tiered single-digit royalties on net product sales - - Rasayana to [...]
Alembic Therapeutics LLC Announces the Launch of PIVYA® (pivmecillinam)
18/02/2026
Pivya ® (pivmecillinam) Tablets, 185mg Now Available by Prescription in the United States BEDMINSTER, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics is pleased to announce the U.S. availability of Pivya [...]
Stoked Bio Secures Exclusive Global License to Develop a Promising New Therapy for Crohn’s Disease
18/02/2026
Enterololin, a narrow-spectrum antibiotic uses a novel mechanism of action to attack the infection HAMILTON, Ontario, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Stoked Bio Inc., a Canadian biotechnology company focused on the [...]
Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting
18/02/2026
- Data presented at Annual Winter Meeting 2026 for the Vascular & Endovascular Surgery Society - - After up to 36 months of follow-up, extremity arterial trauma patients had high rates of limb salvage, low rates of [...]
Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY
18/02/2026
Total Revenue Increased 480% to $92.4 million for Full Year 2025, Q4 Revenue reached $36.6 million IM8 Reaches $10 Million in Monthly Revenue in December 2025, Achieving $120M ARR Milestone Strategic Transformation [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend
18/02/2026
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]
Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need
18/02/2026
Stenoparib is being evaluated in combination with temozolomide clinical benefit in relapsed Small Cell Lung Cancer Trial is fully funded by the U.S. Department of Veterans Affairs and is open for enrollment at 11 VA [...]
Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference
18/02/2026
CLEARWATER, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion ® and the AYON Body [...]
Unnatural Products Announces Licensing Agreement with Novartis to Develop Macrocyclic Peptide Therapeutics
18/02/2026
Collaboration will harness UNP’s AI enhanced macrocycle platform to drug historically “undruggable” targets SANTA CRUZ, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech developing [...]

Pages